Pinned Tweet
This year’s edition of the @ChildrensPhila ACR reunion was a big success! Over 20 years of fellows celebrating with laughs, stories, and shuffleboard! #ACR25 #pedsrheum
Jay Mehta retweeted
At 12, Molly’s ankle injury became months of pain and uncertainty before she was diagnosed with Juvenile Idiopathic Arthritis. With her family’s support, she found remission and became an advocate for others. LISTEN → acr.tw/4gVAEjc
Jay Mehta retweeted
⏰ It's time to apply for the CARRA-@ArthritisFdn Intramural grants! Jan. 15th is the deadline for Letters of Intent (LOIs) for Registry and Biobank-related RFAs for the CARRA-AF grants.
✅ Check out all the grant opportunities and the RFAs here 👉🏼 tinyurl.com/yck2s968
We are absolutely thrilled to welcome 3 future #pedsrheum superstars to the @ChildrensPhila rheum fam!
I'm proud to be a member of @carrainc and to donate on #GivingTuesday to support this incredible organization conducting #pedsrheum research
Join me in donating! This year, your donation will be doubled thanks to the McGrath Family Match!
Donate here: ➡️bit.ly/4fOq6kf
Jay Mehta retweeted
Approx. 50% of patients with pediatric-onset rheumatic disease are lost to follow-up as they transfer to adult care. What can we do? A lot! A few suggestions and resources in the comments. @ACRheum @GotTransition
Great suggestions and insights from @SarahBayefskyMD to help rheumatologists as #pedsrheum patients transition to adult care. #ACR24
It was so great to see all the great work presented by @carrainc members at #ACR24. I feel so fortunate to be part of this community and this organization!
🙌🏽 Thank you to everyone who helped make #ACR24 a great success! It was an honor to connect with our CARRA members, as well as many other rheumatologists, researchers, industry partners, advocates, and families from around the world. 💙
Jay Mehta retweeted
🗨️ Improving JIA outcomes and reducing disparities is challenging, yet we demonstrate that it is feasible using an equity-driven approach"
Healio talked with @DrDNAbel about what her group has learned at @ChildrensPhila👇
healio.com/news/rheumatology…
Jay Mehta retweeted
So grateful for this opportunity from @AcademyHealth and @MooreFound to improve diagnosis for kiddos with rheumatic diseases (and excited to learn more from @UCSF_CoDEx)!!
This Post is from an account that no longer exists. Learn more
Jay Mehta retweeted
🙌 Congratulations to @Annatomiga of @ChildrensPhila! Dr. Costello is the winner of a CARRA-@ArthritisFdn Mentored Career Development Award for her research entitled “Defining and Characterizing Diagnostic Delay in Juvenile Idiopathic Arthritis.”🌟#kidsgetarthritistoo #pedsrheum
Congrats @Annatomiga!! Can’t wait to see what you learn and how you improve the care of kids with #jia. #pedsrheum
So grateful to @carrainc and @ArthritisFdn for this opportunity to study diagnostic delay in JIA and to start figuring out how to get kiddos with arthritis to diagnosis and treatment more quickly!
Another absolutely fabulous @ChildrensPhila #pedsrheum and @PennRheum Fellow Research Day capped off with an invigorating keynote by @MACattackLab.
So much impressive work being done by our fellows!
Jay Mehta retweeted
Are you in #meded #hpe & looking for qualitative research training? Specifically on reflexive thematic analysis and narrative analysis?
Yes?
Come join @dorenebalmer @AKonopasky, Emiko Blalock & I @ChildrensPhila on 4/15 for a full day workshop
Register: bit.ly/3TFaK7V
Jay Mehta retweeted
CARRA Early Investigators and Fellows:
Looking for a way to fit more focused academic writing time into your week? Sign up for a slot in a #carra Writing Accountability Group (WAG) here: redcap.link/3eeungi6
Groups of #pedsrheum writers will start meeting this spring!
Great list of some of the essential #SLE management papers.
So useful for both junior AND experienced clinicians!
Ahead of the@SLEuroSociety this week I was asked by a trainee to share 10 papers that will help junior clinicians when managing #SLE for the first time & thought I'd share the list here too
Please add your 'go to' papers that give an overview of managing the disease clinically
Jay Mehta retweeted
Agree, great job @DrDNAbel! She def pulled some punches. This is a big issue that #PBMs have fought to silence - ppl should be livid, esp in #RareDisease community.
Why do PBM exist? ...
Very proud of @ChildrensPhila #pedsrheum fellow @DrDNAbel for this beautifully written letter in@PhillyInquirer about the absolutely unconscionable rigamarole that is insurance prior authorization.
inquirer.com/opinion/comment…
@ACRheum
@ACRheumDC
@carrainc
Ever been curious about what "Immune Dysregulation" means?
Join the most interesting man in rheumatology, Ed Behrens, as he demystifies it in this great episode with @drkatielockwood
Learn about #immunedysregulation and how Dr. Ed Behrens @ChildrensPhila is using a multidisciplinary team, precision medicine, & collaborative research to improve care for patients with #rarediseases. podcasts.apple.com/us/podcas… #rheumatology @ACRheum
Jay Mehta retweeted
🦓#RareDiseaseDay is close to our heart because CARRA was founded by peds rheumatologists who realized that the only way to advance research in rare pediatric rheumatic diseases was to create a collaborative network and work together. 💙
#Showyourstripes @RareDiseases
Very proud of @ChildrensPhila #pedsrheum fellow @DrDNAbel for this beautifully written letter in@PhillyInquirer about the absolutely unconscionable rigamarole that is insurance prior authorization.
inquirer.com/opinion/comment…
@ACRheum
@ACRheumDC
@carrainc
Jay Mehta retweeted
Check out "The Future Looks Bright: Managing PsO and PsA in Youth" episode of the Psound Bytes Podcast, as #ClinicalFutures' Associate Director of Clinical Trials, Dr. Pamela Weiss, discusses the latest research surrounding #psoriaticdisease: apple.co/4bF1ybV
